本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Monte Rosa Therapeutics

14.07
-0.2500-1.75%
盤後14.070.00000.00%19:39 EDT
成交量:117.39萬
成交額:1,658.98萬
市值:12.00億
市盈率:-8.06
高:14.74
開:14.24
低:13.88
收:14.32
52周最高:25.77
52周最低:4.80
股本:8,531.34萬
流通股本:5,447.61萬
量比:1.20
換手率:2.15%
股息:- -
股息率:- -
每股收益(TTM):-1.7450
每股收益(LYR):-0.4650
淨資產收益率:-42.66%
總資產收益率:-21.63%
市淨率:2.46
市盈率(LYR):-30.26

資料載入中...

2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report